Eupraxia Pharmaceuticals Ownership | Who Owns Eupraxia Pharmaceuticals?


OverviewChart

Eupraxia Pharmaceuticals Ownership Summary


Eupraxia Pharmaceuticals is owned by 38.27% institutional investors, 14.70% insiders, and 47.03% retail investors. Scotia capital is the largest institutional shareholder, holding 3.84% of EPRX shares.

EPRX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockEupraxia Pharmaceuticals38.27%14.70%47.03%
SectorHealthcare Stocks 42.64%10.86%46.50%
IndustryBiotech Stocks 45.45%10.77%43.78%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Scotia capital1.29M3.84%$9.60M
Ubs group220.02K0.66%$1.66M
Acadian asset management155.77K0.47%$1.17M
Goldman sachs group58.06K0.17%$438.34K
Cibc world market58.05K0.17%$436.54K
Bank of montreal /can/37.25K0.11%$280.08K
Jane street group29.62K0.09%$222.78K
Geode capital management13.90K0.04%$104.94K
Tci wealth advisors11.00K0.03%$83.05K
Td waterhouse canada9.60K0.03%$71.69K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Scotia capital1.29M0.04%$9.60M
Tci wealth advisors11.00K0.00%$83.05K
Acadian asset management155.77K0.00%$1.17M
Cibc world market58.05K0.00%$436.54K
Td waterhouse canada9.60K0.00%$71.69K
Federation des caisses desjardins du quebec9.09K0.00%$67.89K
Ubs group220.02K0.00%$1.66M
Goldman sachs group58.06K0.00%$438.34K
Bank of montreal /can/37.25K0.00%$280.08K
Integrated wealth concepts---

Top Buyers

HolderShares% AssetsChange
Acadian asset management155.77K0.00%134.37K
Ubs group220.02K0.00%124.27K
Cibc world market58.05K0.00%43.05K
Jane street group29.62K-29.62K
Goldman sachs group58.06K0.00%17.96K

Top Sellers

HolderShares% AssetsChange
Alyeska investment group---250.00K
Jpmorgan chase---16.47K
Integrated wealth concepts---12.00K
Federation des caisses desjardins du quebec9.09K0.00%-
Td waterhouse canada9.60K0.00%-

New Positions

HolderShares% AssetsChangeValue
Jane street group29.62K-29.62K$222.78K
Geode capital management13.90K-13.90K$104.94K

Sold Out

HolderChange
Integrated wealth concepts-12.00K
Jpmorgan chase-16.47K
Alyeska investment group-250.00K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20252792.86%12,813,323550.40%38127.17%22144.44%2-60.00%
Jun 30, 20251427.27%1,970,076-9.11%514.87%912.50%5150.00%
Mar 31, 20251122.22%2,167,59318.69%623.11%8100.00%2-50.00%
Dec 31, 2024912.50%1,826,2701.52%520.10%4-33.33%4-
Sep 30, 20248-1,798,9684.16%521.48%6-25.00%--

EPRX Ownership FAQ


Who Owns Eupraxia Pharmaceuticals?

Eupraxia Pharmaceuticals shareholders are primarily institutional investors at 38.27%, followed by 14.70% insiders and 47.03% retail investors. The average institutional ownership in Eupraxia Pharmaceuticals's industry, Biotech Stocks , is 45.45%, which Eupraxia Pharmaceuticals falls below.

Who owns the most shares of Eupraxia Pharmaceuticals?

Eupraxia Pharmaceuticals’s largest shareholders are Scotia capital (1.29M shares, 3.84%), Ubs group (220.02K shares, 0.66%), and Acadian asset management (155.77K shares, 0.47%). Together, they hold 4.96% of Eupraxia Pharmaceuticals’s total shares outstanding.

Does Blackrock own Eupraxia Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Eupraxia Pharmaceuticals.

Who is Eupraxia Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Scotia capital is Eupraxia Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.04% of its assets in 1.29M Eupraxia Pharmaceuticals shares, valued at 9.6M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools